Delivery Order SPE2DB20D3304-SPE2DB25FW5F1

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,313.70, is a Firm Fixed Price Delivery Order to supply the government with FOSAMAX 70 MG TABLET medication. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.98 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG TABLET UU 4S, a medical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $11,283.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order to provide FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a completion date of May 10, 2024. The contract has a Firm Fixed Price pricing type and was not set aside for any specific business category. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,739.23 Firm Fixed Price Delivery Order contract has an ultimate completion date of November 29, 2023 and covers the supply of Fosamax 70 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The award, valued at $4,008.21, is for the delivery of Fosamax 70 MG Tablet pharmaceutical products to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order that runs through January 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,049.61 firm fixed-price delivery order is for medical supplies, specifically FOSAMAX 70 MG TABLET UU 4S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with a value of $6,904.83, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the provision of FOSAMAX 70 MG TABLET and has a Firm Fixed Price pricing type. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,896.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a completion date of July 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,205.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which does not have a set-aside designation, is a delivery order for the supply of pharmaceutical products, specifically the drug Fosamax 70 mg Tablet. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $3,316.92 firm fixed-price delivery order is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a completion date of January 7, 2025. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW5F1
    Delivery Order

This federal contract award, valued at $4,594.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of January 29, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/29/25, 9:44 AM